Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts

Journal of Clinical Investigation

Volumn 113, Issue 5, 2004, Pages 718-726

  Seto, Hiroaki ^a,b   Kamekura, Satoshi ^a   Miura, Toshiki ^a   Yamamoto, Aiichiro ^a   Chikuda, Hirotaka ^a   Ogata, Toru ^a   Hiraoka, Hisatada ^a   Oda, Hiromi ^a   Nakamura, Kozo ^a   Kurosawa, Hisashi ^b   Chug, Ung Il ^c   Kawaguchi, Hiroshi ^a   Tanaka, Sakae ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 10; COLLAGEN TYPE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD PROTEIN; SMAD1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ACTIVIN RECEPTOR; COLLAGEN; DNA BINDING PROTEIN; MAP2K6 PROTEIN, HUMAN; MAP2K6 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; PROTEIN KINASE (CALCIUM,CALMODULIN); RNA; SMAD1 PROTEIN, HUMAN; SMAD1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSDUCTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIOCYTE; SYNOVIUM; ADENOVIRUS; ADULT; AGED; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; NORTHERN BLOTTING; NUDE MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS; ADENOVIRIDAE; ADULT; AGED; ANIMALS; BLOTTING, NORTHERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARTILAGE; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN; COLLAGEN TYPE X; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; MAP KINASE KINASE 6; MICE; MICE, NUDE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOARTHRITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; SYNOVIAL MEMBRANE; TRANS-ACTIVATORS;

EID: 11144357130     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200419899     Document Type: Article

References (46)

1. Hunziker, E.B. 2002. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage. 10:432-463.
2. Poole, A.R., et al. 2001. Composition and structure of articular cartilage: a template for tissue repair. Clin. Orthop. 391:S26-S33.
3. Poole, A.R. 2003. What type of cartilage repair are we attempting to attain? J. Bone Joint Surg. Am. 85-A(Suppl. 2):40-44.
4. Hunziker, E.B. 2003. Tissue engineering of bone and cartilage. From the preclinical model to the patient. Novartis Found. Symp. 249:70-85, 170-174, and 239-141.
5. Bruder, S.P., et al. 1998. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin. Orthop. 355:S247-S256.
6. Matsusue, Y., Yamamuro, T., and Hama, H. 1993. Arthroscopic multiple osteochondral transplantation to the chondral defect in the knee associated with anterior cruciate ligament disruption. Arthroscopy. 9:318-321.
7. Bentley, G., et al. 2003. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J. Bone Joint Surg. Br. 85:223-230.
8. Peterson, L., Minas, T., Brittberg, M., and Lindahl, A. 2003. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J. Bone. Joint Surg. Am. 85-A(Suppl 2):17-24.
9. Peterson, L., Brictberg, M., Kiviranta, I., Akerlund, E.L., and Lindahl, A. 2002. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am. J. Sports Med. 30:2-12.
10. Minas, T., and Nehrer, S. 1997. Current concepts in the treatment of articular cartilage defects. Orthopedics. 20:525-538.
11. Hangody, L., Feczko, P., Bartha, L., Bodo, G., and Kish, G. 2001. Mosaicplasty for the treatment of articular defects of the knee and ankle. Clin. Orthop. 391:S328-S336.
12. Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature. 425:356-361.
13. Takayanagi, H., et al. 1999. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J. Clin. Invest. 104:137-146.
14. Hunziker, E.B., and Rosenberg, LC. 1996. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J. Bone Joint Surg. Am. 78:721-733.
15. Nishimura, K., et al. 1999. Chondroprogenitor cells of synovial tissue. Arthritis Rheum. 42:2631-2637.
16. De Bari, C., Dell'Accio, F., Tylzanowski, P., and Luyten, F.P. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44:1928-1942.
17. De Bari, C., et al. 2003. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160:909-918.
18. O'Connell, J.X. 2000. Pathology of the synovium. Am. J. Clin. Pathol. 114:773-784.
19. Wozney, J.M. 1989. Bone morphogenetic proteins. Prog. Growth Factor Res. 1:267-280.
20. Kulyk, W.M., Rodgers, B.J., Greer, K., and Kosher, R.A. 1989. Promotion of embryonic chick limb cartilage differentiation by transforming growth factor-beta. Dev. Biol. 135:424-430.
21. Lafeber, F.P., Vander Kraan, P.M., Van Roy, J.L., Huber-Bruning, O., and Bijlsma, J.W. 1993. Articular cartilage explant culture; an appropriate in vitro system to compare osteoarthritic and normal human cartilage. Connect. Tissue Res. 29:287-299.
22. Denker, A.E., Nicoll, S.B., and Tuan, R.S. 1995. Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-β 1. Differentiation. 59:25-34.
23. Yamamoto, A., et al. 2003. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts. Arthritis Rheum. 48:2682-2692.
24. Takayanagi, H., et al. 2000. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43:259-269.
25. Tanaka, S., et al. 1998. Modulation of osteoclast function by adenovirus vector-induced epidermal growth factor receptor. J. Bone Miner. Res. 13:1714-1720.
26. Miyake, S., et al. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U. S. A. 93:1320-1324.
27. Fujii, M., et al. 1999. Roles of bone morphogenetic protein type 1 receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell. 10:3801-3813.
28. Enomoto-Iwamoto, M., et al. 2000. Hedgehog proteins stimulate chondrogenic cell differentiation and cartilage formation. J. Bone Miner. Res. 15:1659-1668.
29. Kamekura, S., et al. 2003. Establishment of novel experimental osteoarthritis models in mice. J. Bone Miner. Res. 18:S395.
30. van den Berg, W.B. 2001. Lessons from animal models of osteoarthritis. Curr. Opin. Rheumatol. 13:452-456.
31. Derynck, R., Zhang, Y., and Feng, X.H. 1998. Smads: transcriptional activators of TGF-β responses. Cell. 95:737-740.
32. Miyazono, K., Kusanagi, K., and Inoue, H. 2001. Divergence and convergence of TGF-β/BMP signaling. J. Cell Physiol. 187:265-276.
33. Watanabe, H., de Caestecker, M.P., and Yamada, Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-β-induced aggrecan gene expression in chondrogenic ATDC5 cells. J. Biol. Chem. 276:14466-14473.
34. Miyazono, K. 1997. TGF-β receptors and signal transduction. Int. J. Hematol. 65:97-104.
35. Massague, J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67:753-791.
36. de Crombrugghe, B., et al. 2000. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 19:389-394.
37. Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A., and de Crombrugghe, B. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16:2813-2828.
38. Mi, Z., et al. 2003. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res. 5:R132-R139.
39. Nakamura, K., et al. 1999. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp. Cell Res. 250:351-363.
40. Zhen, X., Wei, L., Wu, Q., Zhang, Y., and Chen, Q. 2001. Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J. Biol. Chem. 276:4879-4885.
41. von der Mark, K., et al. 1995. Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop. Scand. Suppl. 266:125-129.
42. Scharstuhl, A., et al. 2003. Adenoviral overexpression of Smad-7 and Smad-6 differentially regulates TGF-β-mediated chondrocyte proliferation and proteoglycan synthesis. Osteoarthritis Cartilage. 11:773-782.
43. Hidaka, C., et al 2003. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J. Orthop. Res. 21:573-583.
44. Lories, R.J., Derese, I., Ceuppens, J.L., and Luyten, F.P. 2003. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum. 41:2807-2818.
45. Fukui, N., Zhu, Y., Maloney, W.J., Clohisy, J., and Sandell, L.J. 2003. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-α in normal and osteoarthritic chondrocytes. J. Bone Joint Surg. Am. 85-A(Suppl. 3):59-66.
46. Pargellis, C., and Regan, J. 2003. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Curr. Opin. Investig. Drugs. 4:566-571.